Your account is not claimed yet. You can sign up with ORCID to claim your account.

Vincenzo Pota (Pota Vincenzo, V Pota)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Venues

International journal of molecular sciences

Antibiotics (Basel, Switzerland)

Journal of medical case reports

Life (Basel, Switzerland)

University of Campania "Luigi Vanvitelli"

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Campania "Luigi Vanvitelli" Dec 9o 2019

Italy

RTDA :: Dept of Women, Child, General and Specialistic Surgery

Publications

Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, Chiara Tortora, Maria Maddalena Marrapodi, Giulia Giliberti, Domenico Roberti, Maria Caterina Pace, Francesca Rossi
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy. International journal of molecular sciences 24 (4) (2023)
Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, Chiara Tortora, Maria Maddalena Marrapodi, Giulia Giliberti, Domenico Roberti, Maria Caterina Pace, Francesca Rossi
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy. International journal of molecular sciences 24 (4) (2023)
Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, Chiara Tortora, Maria Maddalena Marrapodi, Giulia Giliberti, Domenico Roberti, Maria Caterina Pace, Francesca Rossi
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy. International journal of molecular sciences 24 (4) (2023)
Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, Chiara Tortora, Maria Maddalena Marrapodi, Giulia Giliberti, Domenico Roberti, Maria Caterina Pace, Francesca Rossi
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy. International journal of molecular sciences 24 (4) (2023)
Maura Argenziano, Vincenzo Pota, Alessandra Di Paola, Chiara Tortora, Maria Maddalena Marrapodi, Giulia Giliberti, Domenico Roberti, Maria Caterina Pace, Francesca Rossi
CB2 Receptor as Emerging Anti-Inflammatory Target in Duchenne Muscular Dystrophy. International journal of molecular sciences 24 (4) (2023)
Caterina Aurilio, Pasquale Sansone, Manlio Barbarisi, Vincenzo Pota, Luca Gregorio Giaccari, Francesco Coppolino, Alfonso Barbarisi, Passavanti Maria Beatrice, Maria Caterina Pace
Mechanisms of Action of Carbapenem Resistance. Antibiotics (Basel, Switzerland) 11 (3) (2022)
Sveva Di Franco, Aniello Alfieri, Marco Fiore, Ciro Fittipaldi, Vincenzo Pota, Francesco Coppolino, Pasquale Sansone, Maria Caterina Pace, Passavanti Maria Beatrice
A Literature Overview of Secondary Peritonitis Due to Carbapenem-Resistant Enterobacterales (CRE) in Intensive Care Unit (ICU) Patients. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Pasquale Sansone, Luca Gregorio Giaccari, Caterina Aurilio, Francesco Coppolino, Passavanti Maria Beatrice, Vincenzo Pota, Maria Caterina Pace
Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial. Cancers 14 (16) (2022)
Pasquale Sansone, Luca Gregorio Giaccari, Francesco Coppolino, Caterina Aurilio, Alfonso Barbarisi, Passavanti Maria Beatrice, Vincenzo Pota, Maria Caterina Pace
Cefiderocol for Carbapenem-Resistant Bacteria: Handle with Care! A Review of the Real-World Evidence. Antibiotics (Basel, Switzerland) 11 (7) (2022)
Vincenzo Pota, Francesco Coppolino, Alfonso Barbarisi, Maria Beatrice Passavanti, Caterina Aurilio, Pasquale Sansone, Maria Caterina Pace
Pain in Intensive Care: A Narrative Review. Pain and therapy 11 (2) (2022)
Arta Karruli, Alessia Massa, Lorenzo Bertolino, Roberto Andini, Pasquale Sansone, Salvatore Dongiovanni, Maria Caterina Pace, Vincenzo Pota, Emanuele Durante-Mangoni
Clinical Characteristics and Outcome of MDR/XDR Bacterial Infections in a Neuromuscular Semi-Intensive/Sub-Intensive Care Unit. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Caterina Aurilio, Pasquale Sansone, Antonella Paladini, Manlio Barbarisi, Francesco Coppolino, Vincenzo Pota, Maria Caterina Pace
Multidrug Resistence Prevalence in COVID Area. Life (Basel, Switzerland) 11 (7) (2021)
Sveva Di Franco, Aniello Alfieri, Maria Caterina Pace, Pasquale Sansone, Vincenzo Pota, Ciro Fittipaldi, Marco Fiore, Passavanti Maria Beatrice
Blood Stream Infections from MDR Bacteria. Life (Basel, Switzerland) 11 (6) (2021)
Vincenzo Pota, M B Passavanti, F Coppolino, F Di Zazzo, L De Nardis, R Esposito, M Fiore, G S R C Mangoni di Santostefano, C Aurilio, P Sansone, M C Pace
Septic shock due to Escherichia coli meningoencephalitis treated with immunoglobulin-M-enriched immunoglobulin preparation as adjuvant therapy: a case report. Journal of medical case reports 15 (1) (2021)
Pasquale Sansone, Giaccari Luca Gregorio, Aurilio Caterina, Francesco Coppolino, Passavanti Maria Beatrice, Vincenzo Pota, Pace Maria Caterina
COVID-19 in Low- and Middle-Income Countries (LMICs): A Narrative Review from Prevention to Vaccination Strategy. Vaccines 9 (12) (2021)
L G Giaccari, M C Pace, M B Passavanti, P Sansone, V Esposito, C Aurilio, Vincenzo Pota
Continuous intravenous low-dose diclofenac sodium to control a central fever after ischemic stroke in the intensive care unit: a case report and review of the literature. Journal of medical case reports 13 (1) (2019)
Vincenzo Pota, Pasquale Sansone, Alfonso Fiorelli, Maria Beatrice Passavanti, Mauro D'Amora, Paola Vosa, Elena Bignami, Maria Caterina Pace, Caterina Aurilio
Anesthetic consideration for airway management of patients undergoing endoscopic fibrin glue treatment of tracheobronchial rupture: a case series of three patients. Perioperative medicine (London, England) 7 (2018)

Vincenzo Pota.css-eqlu8i{font-size:small;padding-left:4px;} (Pota Vincenzo, V Pota)

Publication Activity (10 Years)

Top Topics

Top Venues

Vincenzo Pota (Pota Vincenzo, V Pota)